Sexual function

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%